Martin Babler, President, CEO at Principia Biopharma Inc. (PRNB), sold 30,859 shares at $64.10 ($1.9M) on 2020-03-03, disclosed to the SEC on 2020-03-05.
Open-market sale of $1.9M PRNB by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,159 | $0 | 0.0% |
| 2 | $62.45 | 2,085 | $130K | 6.9% |
| 3 | $62.45 | 2,085 | $130K | 6.9% |
| 4 | $63.24 | 7,183 | $454K | 24.1% |
| 5 | $63.24 | 7,183 | $454K | 24.1% |
| 6 | $64.10 | 5,432 |
| $348K |
| 18.5% |
| 7 | $64.10 | 5,432 | $348K | 18.5% |
| 8 | $64.83 | 300 | $19K | 1.0% |
| Total | $61.08 avg | 30,859 | $1.9M | 100% |
| Filing → |
| PRNB | SELL | 2019-12-19 | $2.8M | — | Filing → |